Skip to main content
NCBI home page
The EMBO Journal logoLink to The EMBO Journal
. 1999 Apr 15;18(8):2127–2136. doi: 10.1093/emboj/18.8.2127

Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

A Kamiya 1, T Kinoshita 1, Y Ito 1, T Matsui 1, Y Morikawa 1, E Senba 1, K Nakashima 1, T Taga 1, K Yoshida 1, T Kishimoto 1, A Miyajima 1
PMCID: PMC1171297  PMID: 10205167

Abstract

Fetal liver, the major site of hematopoiesis during embryonic development, acquires additional various metabolic functions near birth. Although liver development has been characterized biologically as consisting of several distinct steps, the molecular events accompanying this process are just beginning to be characterized. In this study, we have established a novel culture system of fetal murine hepatocytes and investigated factors required for development of hepatocytes. We found that oncostatin M (OSM), an interleukin-6 family cytokine, in combination with glucocorticoid, induced maturation of hepatocytes as evidenced by morphological changes that closely resemble more differentiated hepatocytes, expression of hepatic differentiation markers and intracellular glycogen accumulation. Consistent with these in vitro observations, livers from mice deficient for gp130, an OSM receptor subunit, display defects in maturation of hepatocytes. Interestingly, OSM is expressed in CD45(+) hematopoietic cells in the developing liver, whereas the OSM receptor is expressed predominantly in hepatocytes. These results suggest a paracrine mechanism of hepatogenesis; blood cells, transiently expanding in the fetal liver, produce OSM to promote development of hepatocytes in vivo.

Full Text

The Full Text of this article is available as a PDF (498.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelev G. I. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv Cancer Res. 1971;14:295–358. doi: 10.1016/s0065-230x(08)60523-0. [DOI] [PubMed] [Google Scholar]
  2. Baumann H., Ziegler S. F., Mosley B., Morella K. K., Pajovic S., Gearing D. P. Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells. J Biol Chem. 1993 Apr 25;268(12):8414–8417. [PubMed] [Google Scholar]
  3. Bazan J. F. Neuropoietic cytokines in the hematopoietic fold. Neuron. 1991 Aug;7(2):197–208. doi: 10.1016/0896-6273(91)90258-2. [DOI] [PubMed] [Google Scholar]
  4. Bruce A. G., Hoggatt I. H., Rose T. M. Oncostatin M is a differentiation factor for myeloid leukemia cells. J Immunol. 1992 Aug 15;149(4):1271–1275. [PubMed] [Google Scholar]
  5. Burgess-Beusse B. L., Darlington G. J. C/EBPalpha is critical for the neonatal acute-phase response to inflammation. Mol Cell Biol. 1998 Dec;18(12):7269–7277. doi: 10.1128/mcb.18.12.7269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bélanger L., Frain M., Baril P., Gingras M. C., Bartkowiak J., Sala-Trepat J. M. Glucocorticosteroid suppression of alpha1-fetoprotein synthesis in developing rat liver. Evidence for selective gene repression at the transcriptional level. Biochemistry. 1981 Nov 10;20(23):6665–6672. doi: 10.1021/bi00526a022. [DOI] [PubMed] [Google Scholar]
  7. Cake M. H. Induction of tyrosine aminotransferase in utero by anti-insulin agents. Biochem J. 1986 Sep 15;238(3):927–929. doi: 10.1042/bj2380927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Cole T. J., Blendy J. A., Monaghan A. P., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummler E., Unsicker K., Schütz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 1995 Jul 1;9(13):1608–1621. doi: 10.1101/gad.9.13.1608. [DOI] [PubMed] [Google Scholar]
  10. Cressman D. E., Greenbaum L. E., DeAngelis R. A., Ciliberto G., Furth E. E., Poli V., Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 1996 Nov 22;274(5291):1379–1383. doi: 10.1126/science.274.5291.1379. [DOI] [PubMed] [Google Scholar]
  11. Derman E., Krauter K., Walling L., Weinberger C., Ray M., Darnell J. E., Jr Transcriptional control in the production of liver-specific mRNAs. Cell. 1981 Mar;23(3):731–739. doi: 10.1016/0092-8674(81)90436-0. [DOI] [PubMed] [Google Scholar]
  12. Douarin N. M. An experimental analysis of liver development. Med Biol. 1975 Dec;53(6):427–455. [PubMed] [Google Scholar]
  13. Foster D. O., Ray P. D., Lardy H. A. Studies on the mechanisms underlying adaptive changes in rat liver phosphoenolpyruvate carboxykinase. Biochemistry. 1966 Feb;5(2):555–562. doi: 10.1021/bi00866a022. [DOI] [PubMed] [Google Scholar]
  14. Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 1992 Mar 13;255(5050):1434–1437. doi: 10.1126/science.1542794. [DOI] [PubMed] [Google Scholar]
  15. Gearing D. P., Thut C. J., VandeBos T., Gimpel S. D., Delaney P. B., King J., Price V., Cosman D., Beckmann M. P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 1991 Oct;10(10):2839–2848. doi: 10.1002/j.1460-2075.1991.tb07833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grove R. I., Eberhardt C., Abid S., Mazzucco C., Liu J., Kiener P., Todaro G., Shoyab M. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):823–827. doi: 10.1073/pnas.90.3.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haber B. A., Chin S., Chuang E., Buikhuisen W., Naji A., Taub R. High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest. 1995 Feb;95(2):832–841. doi: 10.1172/JCI117733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hilberg F., Aguzzi A., Howells N., Wagner E. F. c-jun is essential for normal mouse development and hepatogenesis. Nature. 1993 Sep 9;365(6442):179–181. doi: 10.1038/365179a0. [DOI] [PubMed] [Google Scholar]
  19. Ho K. K., Cake M. H., Yeoh G. C., Oliver I. T. Insulin antagonism of glucocorticoid induction of tyrosine aminotransferase in cultured foetal hepatocytes. Eur J Biochem. 1981 Aug;118(1):137–142. doi: 10.1111/j.1432-1033.1981.tb05496.x. [DOI] [PubMed] [Google Scholar]
  20. Houssaint E. Differentiation of the mouse hepatic primordium. I. An analysis of tissue interactions in hepatocyte differentiation. Cell Differ. 1980 Oct;9(5):269–279. doi: 10.1016/0045-6039(80)90026-3. [DOI] [PubMed] [Google Scholar]
  21. Hu Z., Evarts R. P., Fujio K., Marsden E. R., Thorgeirsson S. S. Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat. Am J Pathol. 1993 Jun;142(6):1823–1830. [PMC free article] [PubMed] [Google Scholar]
  22. Ichihara M., Hara T., Kim H., Murate T., Miyajima A. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood. 1997 Jul 1;90(1):165–173. [PubMed] [Google Scholar]
  23. Johnson G. R., Moore M. A. Role of stem cell migration in initiation of mouse foetal liver haemopoiesis. Nature. 1975 Dec 25;258(5537):726–728. doi: 10.1038/258726a0. [DOI] [PubMed] [Google Scholar]
  24. Kagoshima M., Kinoshita T., Matsumoto K., Nakamura T. Developmental changes in hepatocyte growth factor mRNA and its receptor in rat liver, kidney and lung. Eur J Biochem. 1992 Nov 15;210(1):375–380. doi: 10.1111/j.1432-1033.1992.tb17431.x. [DOI] [PubMed] [Google Scholar]
  25. Kawasaki K., Gao Y. H., Yokose S., Kaji Y., Nakamura T., Suda T., Yoshida K., Taga T., Kishimoto T., Kataoka H. Osteoclasts are present in gp130-deficient mice. Endocrinology. 1997 Nov;138(11):4959–4965. doi: 10.1210/endo.138.11.5534. [DOI] [PubMed] [Google Scholar]
  26. Kinoshita T., Tashiro K., Nakamura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1229–1234. doi: 10.1016/0006-291x(89)92733-2. [DOI] [PubMed] [Google Scholar]
  27. Lindberg R. A., Juan T. S., Welcher A. A., Sun Y., Cupples R., Guthrie B., Fletcher F. A. Cloning and characterization of a specific receptor for mouse oncostatin M. Mol Cell Biol. 1998 Jun;18(6):3357–3367. doi: 10.1128/mcb.18.6.3357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Liu J., Modrell B., Aruffo A., Marken J. S., Taga T., Yasukawa K., Murakami M., Kishimoto T., Shoyab M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem. 1992 Aug 25;267(24):16763–16766. [PubMed] [Google Scholar]
  29. Malik N., Kallestad J. C., Gunderson N. L., Austin S. D., Neubauer M. G., Ochs V., Marquardt H., Zarling J. M., Shoyab M., Wei C. M. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol. 1989 Jul;9(7):2847–2853. doi: 10.1128/mcb.9.7.2847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Matsumoto K., Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun. 1997 Oct 29;239(3):639–644. doi: 10.1006/bbrc.1997.7517. [DOI] [PubMed] [Google Scholar]
  31. Michalopoulos G. K., DeFrances M. C. Liver regeneration. Science. 1997 Apr 4;276(5309):60–66. doi: 10.1126/science.276.5309.60. [DOI] [PubMed] [Google Scholar]
  32. Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L. S., Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 1996 Dec 20;271(51):32635–32643. doi: 10.1074/jbc.271.51.32635. [DOI] [PubMed] [Google Scholar]
  33. Mukouyama Y., Hara T., Xu M., Tamura K., Donovan P. J., Kim H., Kogo H., Tsuji K., Nakahata T., Miyajima A. In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region. Immunity. 1998 Jan;8(1):105–114. doi: 10.1016/s1074-7613(00)80463-x. [DOI] [PubMed] [Google Scholar]
  34. NEMETH A. M., INSULL W., Jr, FLEXNER L. B. Glycogenesis in the liver of the fetal guinea pig. J Biol Chem. 1954 Jun;208(2):765–772. [PubMed] [Google Scholar]
  35. Nagao M., Nakamura T., Ichihara A. Developmental control of gene expression of tryptophan 2,3-dioxygenase in neonatal rat liver. Biochim Biophys Acta. 1986 Aug 22;867(4):179–186. doi: 10.1016/0167-4781(86)90032-1. [DOI] [PubMed] [Google Scholar]
  36. Nakamura T., Tomita Y., Hirai R., Yamaoka K., Kaji K., Ichihara A. Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun. 1985 Dec 31;133(3):1042–1050. doi: 10.1016/0006-291x(85)91241-0. [DOI] [PubMed] [Google Scholar]
  37. Nawa K., Nakamura T., Kumatori A., Noda C., Ichihara A. Glucocorticoid-dependent expression of the albumin gene in adult rat hepatocytes. J Biol Chem. 1986 Dec 25;261(36):16883–16888. [PubMed] [Google Scholar]
  38. Nettleton G. S., Carpenter A. M. Studies of the mechanism of the periodic acid-Schiff histochemical reaction for glycogen using infrared spectroscopy and model chemical compounds. Stain Technol. 1977 Mar;52(2):63–77. doi: 10.3109/10520297709116750. [DOI] [PubMed] [Google Scholar]
  39. Nishina H., Vaz C., Billia P., Nghiem M., Sasaki T., De la Pompa J. L., Furlonger K., Paige C., Hui C., Fischer K. D. Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development. 1999 Feb;126(3):505–516. doi: 10.1242/dev.126.3.505. [DOI] [PubMed] [Google Scholar]
  40. Noda C., Fukushima C., Fujiwara T., Matsuda K., Kobune Y., Ichihara A. Developmental regulation of rat serine dehydratase gene expression: evidence for the presence of a repressor in fetal hepatocytes. Biochim Biophys Acta. 1994 Mar 1;1217(2):163–173. doi: 10.1016/0167-4781(94)90030-2. [DOI] [PubMed] [Google Scholar]
  41. Noda C., Ohguri M., Ichihara A. Developmental and growth-related regulation of expression of serine dehydratase mRNA in rat liver. Biochem Biophys Res Commun. 1990 Apr 16;168(1):335–342. doi: 10.1016/0006-291x(90)91713-3. [DOI] [PubMed] [Google Scholar]
  42. Noji S., Tashiro K., Koyama E., Nohno T., Ohyama K., Taniguchi S., Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun. 1990 Nov 30;173(1):42–47. doi: 10.1016/s0006-291x(05)81018-6. [DOI] [PubMed] [Google Scholar]
  43. Panduro A., Shalaby F., Shafritz D. A. Changing patterns of transcriptional and post-transcriptional control of liver-specific gene expression during rat development. Genes Dev. 1987 Dec;1(10):1172–1182. doi: 10.1101/gad.1.10.1172. [DOI] [PubMed] [Google Scholar]
  44. Pennica D., Shaw K. J., Swanson T. A., Moore M. W., Shelton D. L., Zioncheck K. A., Rosenthal A., Taga T., Paoni N. F., Wood W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 1995 May 5;270(18):10915–10922. doi: 10.1074/jbc.270.18.10915. [DOI] [PubMed] [Google Scholar]
  45. Philippidis H., Ballard F. J. The development of gluconeogenesis in rat liver: experiments in vivo. Biochem J. 1969 Jul;113(4):651–657. doi: 10.1042/bj1130651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ramadori G., Neubauer K., Odenthal M., Nakamura T., Knittel T., Schwögler S., Meyer zum Büschenfelde K. H. The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is downregulated during cell growth and by transforming growth factor-beta. Biochem Biophys Res Commun. 1992 Mar 16;183(2):739–742. doi: 10.1016/0006-291x(92)90545-v. [DOI] [PubMed] [Google Scholar]
  47. Richards C. D., Brown T. J., Shoyab M., Baumann H., Gauldie J. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J Immunol. 1992 Mar 15;148(6):1731–1736. [PubMed] [Google Scholar]
  48. Richards C. D., Kerr C., Tanaka M., Hara T., Miyajima A., Pennica D., Botelho F., Langdon C. M. Regulation of tissue inhibitor of metalloproteinase-1 in fibroblasts and acute phase proteins in hepatocytes in vitro by mouse oncostatin M, cardiotrophin-1, and IL-6. J Immunol. 1997 Sep 1;159(5):2431–2437. [PubMed] [Google Scholar]
  49. Rose T. M., Bruce A. G. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8641–8645. doi: 10.1073/pnas.88.19.8641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sanchez A., Alvarez A. M., Benito M., Fabregat I. Transforming growth factor beta modulates growth and differentiation of fetal hepatocytes in primary culture. J Cell Physiol. 1995 Nov;165(2):398–405. doi: 10.1002/jcp.1041650221. [DOI] [PubMed] [Google Scholar]
  51. Sassi H., Pictet R., Grange T. Glucocorticoids are insufficient for neonatal gene induction in the liver. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5621–5625. doi: 10.1073/pnas.95.10.5621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Shelly L. L., Tynan W., Schmid W., Schütz G., Yeoh G. C. Hepatocyte differentiation in vitro: initiation of tyrosine aminotransferase expression in cultured fetal rat hepatocytes. J Cell Biol. 1989 Dec;109(6 Pt 2):3403–3410. doi: 10.1083/jcb.109.6.3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Shiojiri N., Lemire J. M., Fausto N. Cell lineages and oval cell progenitors in rat liver development. Cancer Res. 1991 May 15;51(10):2611–2620. [PubMed] [Google Scholar]
  54. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997;15:797–819. doi: 10.1146/annurev.immunol.15.1.797. [DOI] [PubMed] [Google Scholar]
  55. Tanaka M., Hara T., Copeland N. G., Gilbert D. J., Jenkins N. A., Miyajima A. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit. Blood. 1999 Feb 1;93(3):804–815. [PubMed] [Google Scholar]
  56. Thoma B., Bird T. A., Friend D. J., Gearing D. P., Dower S. K. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem. 1994 Feb 25;269(8):6215–6222. [PubMed] [Google Scholar]
  57. Tilghman S. M., Belayew A. Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5254–5257. doi: 10.1073/pnas.79.17.5254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Wang N. D., Finegold M. J., Bradley A., Ou C. N., Abdelsayed S. V., Wilde M. D., Taylor L. R., Wilson D. R., Darlington G. J. Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 1995 Aug 25;269(5227):1108–1112. doi: 10.1126/science.7652557. [DOI] [PubMed] [Google Scholar]
  59. Wijelath E. S., Carlsen B., Cole T., Chen J., Kothari S., Hammond W. P. Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J Cell Sci. 1997 Apr;110(Pt 7):871–879. doi: 10.1242/jcs.110.7.871. [DOI] [PubMed] [Google Scholar]
  60. Yamane A., Seetharam L., Yamaguchi S., Gotoh N., Takahashi T., Neufeld G., Shibuya M. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene. 1994 Sep;9(9):2683–2690. [PubMed] [Google Scholar]
  61. Yasukawa K., Futatsugi K., Saito T., Yawata H., Narazaki M., Suzuki H., Taga T., Kishimoto T. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol Lett. 1992 Feb;31(2):123–130. doi: 10.1016/0165-2478(92)90138-e. [DOI] [PubMed] [Google Scholar]
  62. Yawata H., Yasukawa K., Natsuka S., Murakami M., Yamasaki K., Hibi M., Taga T., Kishimoto T. Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J. 1993 Apr;12(4):1705–1712. doi: 10.1002/j.1460-2075.1993.tb05815.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Yeung D., Oliver I. T. Gluconeogenesis from amino acids in neonatal rat liver. Biochem J. 1967 Jun;103(3):744–748. doi: 10.1042/bj1030744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):407–411. doi: 10.1073/pnas.93.1.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Yoshimura A., Ichihara M., Kinjyo I., Moriyama M., Copeland N. G., Gilbert D. J., Jenkins N. A., Hara T., Miyajima A. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 1996 Mar 1;15(5):1055–1063. [PMC free article] [PubMed] [Google Scholar]
  66. de Juan C., Benito M., Alvarez A., Fabregat I. Differential proliferative response of cultured fetal and regenerating hepatocytes to growth factors and hormones. Exp Cell Res. 1992 Oct;202(2):495–500. doi: 10.1016/0014-4827(92)90104-g. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES